What clinical trials are available for locally advanced Prostate Cancer

Prostate CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Clinical Trials for Locally Advanced Prostate Cancer

I appreciate your question about clinical trial options. Based on the educational resources available to me, I can provide some important context about how trials are organized for prostate cancer, though I want to be transparent about what information I have.

What the Evidence Shows About Trial Organization

According to expert guidance from leading prostate cancer researchers, clinical trials for prostate cancer are organized by disease stage and treatment history. Dr. [removed] Armstrong from Duke University notes that researchers "try to organize our studies so that we have something for everybody, whether it's localized prostate cancer, PSA recurrence, or metastatic hormone-sensitive."

However, the specific resources I have access to focus more heavily on:

  • Localized prostate cancer (cancer confined to the prostate)
  • Metastatic disease (cancer that has spread beyond the prostate)
  • Castrate-resistant prostate cancer (cancer that continues growing despite hormone therapy)

What "Locally Advanced" Typically Means

Locally advanced prostate cancer generally refers to cancer that has grown beyond the prostate capsule but hasn't spread to distant sites. This is an important distinction because treatment approaches differ based on whether cancer is truly localized versus locally advanced.

Questions to Ask Your Oncologist

Since locally advanced disease sits in a specific category, I'd recommend asking your care team:

  1. "Does my cancer meet the criteria for 'locally advanced' or is it better classified as localized with high-risk features?" (This affects which trials you'd be eligible for)

  2. "Are there clinical trials available at your institution or nearby cancer centers for my specific stage?"

  3. "What are the standard treatment options for locally advanced prostate cancer, and how do clinical trials compare?"

  4. "Can you refer me to a trial-matching service or resource like Massive Bio or ClinicalTrials.gov?"

  5. "Are there trials combining radiation therapy with systemic therapy (hormone therapy or chemotherapy) that might be appropriate for my case?"

How to Find Trials

  • ClinicalTrials.gov - Search by disease stage and location
  • Massive Bio - Offers AI-powered clinical trial matching for prostate cancer patients
  • Your cancer center's research department - Many major institutions have dedicated trial coordinators
  • NCCN (National Comprehensive Cancer Network) - Provides guidelines on standard approaches and trial availability

Important Context

According to the treatment guidance I have, the standard of care for prostate cancer has shifted significantly toward treatment intensification - meaning combining multiple therapies rather than single-agent treatment. For locally advanced disease, this might involve combinations of radiation therapy, hormone therapy, and potentially chemotherapy, depending on your specific risk factors.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncologist is best positioned to:

  • Confirm your exact disease stage
  • Identify which trials match your specific situation
  • Discuss the pros and cons of trial participation versus standard treatment
  • Help you understand eligibility requirements

Would you like me to explain any of these treatment approaches or help you prepare questions for your care team?

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: